Viewing Study NCT06656559


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-01-03 @ 10:00 PM
Study NCT ID: NCT06656559
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-24
First Post: 2024-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolimab and Surufatinib Sequential Therapy for Unresectable Biliary Tract Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module